• Academy Events

  • Regenerative Medicine: Transitioning Therapeutics from Cells to the Clinic

    Monday, February 22, 2016 | 9:00 AM - 5:00 PM
    The New York Academy of Sciences

    Presented by the Biochemical Pharmacology Discussion Group

    Related Content

    The field of regenerative medicine is burgeoning with academic and industry groups, actively developing cell-based therapeutic products. These therapies aim to enhance or correct cell function, often utilizing genetic modification or gene editing approaches. Preclinical and early stage clinical trials have demonstrated that cell-based therapies can provide local and systemic clinical benefit by driving production and secretion of biologically active mediators such as cytokines and growth factors, reversing disease progression and promoting healing. Notably, cell-based therapies are already commercially available for cartilage injury and severe burn injuries, and clinical trials have shown promising results in diabetes, kidney disease, heart disease, stroke, cancer, spinal cord injury, and graft versus host disease (GVHD).

    To advance the development of cell-based therapies, next generation approaches for scaled manufacturing and formulation of cell-based therapeutic products are being implemented, enabling distribution demands in compliance with regulatory guidelines. Moreover, as numerous prospective therapeutics are targeted to clinical indications where there are no approved therapies, adaptive clinical trial strategies along with novel outcome endpoints for registration must be contemplated. These manufacturing and clinical endeavors require focused interactions between academia and industry to discover and translate key innovations in these areas. The symposium will unite key representatives from both academia and industry to discuss the challenges and important new developments critical for the advancement of the regenerative medicine field.

    *Reception to follow.

    Call for Poster Abstracts

    Abstract submissions are invited for a poster session. For complete submission instructions, please send an email to with the words "Abstract Information" in the subject line. The deadline for abstract submission is February 5, 2016.

    Registration Pricing

    Member $60
    Member (Student / Postdoc / Resident / Fellow) $25
    Nonmember (Academia) $105
    Nonmember (Corporate) $160
    Nonmember (Non-profit) $105
    Nonmember (Student / Postdoc / Resident / Fellow) $70


    This event will also be broadcast as a webinar; registration is required.

    Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City where possible.

    Webinar Pricing

    Member $30
    Member (Student / Postdoc / Resident / Fellow) $15
    Nonmember (Academia) $65
    Nonmember (Corporate) $85
    Nonmember (Non-profit) $65
    Nonmember (Student / Postdoc / Resident / Fellow) $45


    The Biochemical Pharmacology Discussion Group is proudly supported by

    • Boehringer Ingelheim
    • Pfizer


    American Chemical Society